Drug Profile
Interferon beta gene therapy
Latest Information Update: 03 Sep 2004
Price :
$50
*
At a glance
- Originator Transgene
- Class Antivirals; Cytokine genes; Gene therapies; Interferons
- Mechanism of Action Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bladder cancer; HIV infections
Most Recent Events
- 02 Dec 2002 Discontinued - Preclinical for Bladder cancer in USA (unspecified route)
- 07 Mar 2002 Discontinued - Preclinical for HIV infections treatment in France (unspecified route)
- 13 Jul 1999 Preclinical development for Bladder cancer in USA (Unknown route)